332 related articles for article (PubMed ID: 8930475)
1. IL-1 beta protein in human skin lymph does not discriminate allergic from irritant contact dermatitis.
Brand CU; Hunziker T; Yawalkar N; Braathen LR
Contact Dermatitis; 1996 Sep; 35(3):152-6. PubMed ID: 8930475
[TBL] [Abstract][Full Text] [Related]
2. Human skin lymph derived from irritant and allergic contact dermatitis: interleukin 10 is increased selectively in elicitation reactions.
Brand CU; Yawalkar N; Hunziker T; Braathen LR
Dermatology; 1997; 194(3):221-8. PubMed ID: 9187837
[TBL] [Abstract][Full Text] [Related]
3. Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin.
Kondo S; Pastore S; Shivji GM; McKenzie RC; Sauder DN
Lymphokine Cytokine Res; 1994 Dec; 13(6):367-75. PubMed ID: 7703310
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 expression in human afferent lymph derived from the induction phase of allergic contact dermatitis.
Yawalkar N; Brand CU; Braathen LR
Br J Dermatol; 1998 Feb; 138(2):297-300. PubMed ID: 9602878
[TBL] [Abstract][Full Text] [Related]
5. sICAM-1, sE-selectin and sVCAM-1 are constitutively present in human skin lymph and increased in allergic contact dermatitis.
Ballmer-Weber BK; Braathen LR; Brand CU
Arch Dermatol Res; 1997 Apr; 289(5):251-5. PubMed ID: 9164633
[TBL] [Abstract][Full Text] [Related]
6. Differential epidermal expression of the invariant chain in allergic and irritant contact dermatitis.
Emilson A; Lindberg M; Scheynius A
Acta Derm Venereol; 1998 Nov; 78(6):402-7. PubMed ID: 9833035
[TBL] [Abstract][Full Text] [Related]
7. Cytokine mRNA expression in human epidermis after patch treatment with rhus and sodium lauryl sulfate.
Ryan CA; Gerberick GF
Am J Contact Dermat; 1999 Sep; 10(3):127-35. PubMed ID: 10444105
[TBL] [Abstract][Full Text] [Related]
8. Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing.
Pichowski JS; Cumberbatch M; Dearman ; Basketter DA; Kimber I
Toxicol In Vitro; 2000 Aug; 14(4):351-60. PubMed ID: 10906442
[TBL] [Abstract][Full Text] [Related]
9. IRRITANT AND ALLERGIC CONTACT DERMATITIS - SKIN LESION CHARACTERISTICS.
Novak-Bilić G; Vučić M; Japundžić I; Meštrović-Štefekov J; Stanić-Duktaj S; Lugović-Mihić L
Acta Clin Croat; 2018 Dec; 57(4):713-720. PubMed ID: 31168208
[TBL] [Abstract][Full Text] [Related]
10. In vivo cytokine profiles in allergic and irritant contact dermatitis.
Hoefakker S; Caubo M; van 't Erve EH; Roggeveen MJ; Boersma WJ; van Joost T; Notten WR; Claassen E
Contact Dermatitis; 1995 Oct; 33(4):258-66. PubMed ID: 8654078
[TBL] [Abstract][Full Text] [Related]
11. Relationship between 2,4-dinitrochlorobenzene elicitation responses and individual irritant threshold.
Smith HR; Kelly DA; Young AR; Basketter DB; McFadden JP
Contact Dermatitis; 2002 Feb; 46(2):97-100. PubMed ID: 11918603
[TBL] [Abstract][Full Text] [Related]
12. Rosettes of Langerhans cells and activated T cells in human skin lymph derived from irritant contact dermatitis.
Brand CU; Hunziker T; Gerber HA; Schaffner T; Limat A; Braathen LR
Adv Exp Med Biol; 1995; 378():527-9. PubMed ID: 8526133
[No Abstract] [Full Text] [Related]
13. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions.
Flier J; Boorsma DM; Bruynzeel DP; Van Beek PJ; Stoof TJ; Scheper RJ; Willemze R; Tensen CP
J Invest Dermatol; 1999 Oct; 113(4):574-8. PubMed ID: 10504443
[TBL] [Abstract][Full Text] [Related]
14. An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions.
Homey B; von Schilling C; Blümel J; Schuppe HC; Ruzicka T; Ahr HJ; Lehmann P; Vohr HW
Toxicol Appl Pharmacol; 1998 Nov; 153(1):83-94. PubMed ID: 9875302
[TBL] [Abstract][Full Text] [Related]
15. Activated immunocompetent cells in human skin lymph derived from irritant contact dermatitis: an immunomorphological study.
Brand CU; Hunziker T; Schaffner T; Limat A; Gerber HA; Braathen LR
Br J Dermatol; 1995 Jan; 132(1):39-45. PubMed ID: 7756150
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the CD28 molecule to allergic and irritant-induced skin reactions in CD28 -/- mice.
Kondo S; Kooshesh F; Wang B; Fujisawa H; Sauder DN
J Immunol; 1996 Dec; 157(11):4822-9. PubMed ID: 8943384
[TBL] [Abstract][Full Text] [Related]
17. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
Arancioglu S; Ulker OC; Karakaya A
Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
[TBL] [Abstract][Full Text] [Related]
18. Phenotype of Langerhans cells in human afferent skin lymph derived from allergic contact dermatitis.
Brand CU; Gerber HA; Hunziker T; Schaffner T; Limat A; Brathen LR
Exp Dermatol; 1993 Dec; 2(6):274-9. PubMed ID: 8162348
[TBL] [Abstract][Full Text] [Related]
19. Epidermal cytokines in experimental contact dermatitis.
Corsini E; Galli CL
Toxicology; 2000 Jan; 142(3):203-11. PubMed ID: 10667891
[TBL] [Abstract][Full Text] [Related]
20. Early molecular events in the induction phase of contact sensitivity.
Enk AH; Katz SI
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1398-402. PubMed ID: 1741395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
